Ledger.Open graph →
SEC Form D · filed March 22, 2019

AgeX Therapeutics, Inc

Offering
$5.0M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ALAMEDA, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Michael D. West · Alameda, CAExec · DirectorBioTime, Inc · Alameda, CAPromoterMichael H. Mulroy · Alameda, CADirectorRussell D. Skibsted · Alameda, CAExecJohn F. Mauldin · Alameda, CADirectorThomas L. Mcdougal · DALLAS, TXDirectorEric L. Langford · DALLAS, TXExecSteven B. Clapp · DALLAS, TXExec · DirectorPatrick L. Howard · DALLAS, TXPromoterThomas T. Suminski · Northbrook, ILDirectorAnnalisa F. Jenkins · Alameda, CADirectorGregory D. Bailey · Alameda, CADirectorHeini Zachariassen · San Francisco, CADirectorNeeraj Arora · San Francisco, CAExecMatt Gibbs · Fort Collins, COPromoterBob J. Gibbs · Fort Collins, COExec · DirectorNiraj Gupta · New York, NYDirectorAnnalisa F. Jenkins · Alameda, CADirectorGregory D. Bailey · Alameda, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗